Dr Kimberly Ann Bailey Dexter, NURSE PRACTITIONER - Medicare Nurse Practitioner in Chesterfield, VA

Dr Kimberly Ann Bailey Dexter, NURSE PRACTITIONER is a medicare enrolled "Nurse Practitioner - Psychiatric/mental Health" in Chesterfield, Virginia. She graduated from nursing school in 2020 and has 4 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice County Of Chesterfield Virginia and her current practice location is 6801 Lucy Corr Ct, Chesterfield, Virginia. You can reach out to her office (for appointments etc.) via phone at (804) 751-7215.

Dr Kimberly Ann Bailey Dexter is licensed to practice in Virginia (license number 0024179509) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1235764309.

Contact Information

Dr Kimberly Ann Bailey Dexter, NURSE PRACTITIONER
6801 Lucy Corr Ct,
Chesterfield, VA 23832-6657
(804) 751-7215
Not Available



Provider's Profile

Full NameDr Kimberly Ann Bailey Dexter
GenderFemale
SpecialityNurse Practitioner
Experience4 Years
Location6801 Lucy Corr Ct, Chesterfield, Virginia
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Kimberly Ann Bailey Dexter graduated from nursing school in 2020
  NPI Data:
  • NPI Number: 1235764309
  • Provider Enumeration Date: 03/09/2020
  • Last Update Date: 09/09/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 8921417098
  • Enrollment ID: I20210503001734

Medical Identifiers

Medical identifiers for Dr Kimberly Ann Bailey Dexter such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1235764309NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
163WP0809XRegistered Nurse - Psychiatric/mental Health, Adult 000123867 (Virginia)Secondary
363LP0808XNurse Practitioner - Psychiatric/mental Health RN1059614 (District Of Columbia)Secondary
363LP0808XNurse Practitioner - Psychiatric/mental Health 0024179509 (Virginia)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
County Of Chesterfield Virginia054724594612

News Archive

Sports playbook can help generate more accurate prognoses for cancer patients

In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election.

Malvern and Paraytec enter into development and technology licensing agreement

Malvern Panalytical (Malvern Panalytical, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix® technology being added to Malvern Panalytical's materials characterization portfolio. The agreement will give Malvern Panalytical exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

American Brain Tumor Association awards $100,000 clinical research grant

The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Kimberly Ann Bailey Dexter allows following entities to bill medicare on her behalf.
Entity NameMcv Associated Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710959457
PECOS PAC ID: 4385542117
Enrollment ID: O20031230000559

News Archive

Sports playbook can help generate more accurate prognoses for cancer patients

In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election.

Malvern and Paraytec enter into development and technology licensing agreement

Malvern Panalytical (Malvern Panalytical, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix® technology being added to Malvern Panalytical's materials characterization portfolio. The agreement will give Malvern Panalytical exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

American Brain Tumor Association awards $100,000 clinical research grant

The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.

Read more Medical News

› Verified 9 days ago

Entity NameHampton-newport News Community Services Board
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659424448
PECOS PAC ID: 0446247480
Enrollment ID: O20040429001348

News Archive

Sports playbook can help generate more accurate prognoses for cancer patients

In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election.

Malvern and Paraytec enter into development and technology licensing agreement

Malvern Panalytical (Malvern Panalytical, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix® technology being added to Malvern Panalytical's materials characterization portfolio. The agreement will give Malvern Panalytical exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

American Brain Tumor Association awards $100,000 clinical research grant

The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.

Read more Medical News

› Verified 9 days ago

Entity NameCounty Of Chesterfield Virginia
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1336293000
PECOS PAC ID: 0547245946
Enrollment ID: O20040621000919

News Archive

Sports playbook can help generate more accurate prognoses for cancer patients

In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election.

Malvern and Paraytec enter into development and technology licensing agreement

Malvern Panalytical (Malvern Panalytical, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix® technology being added to Malvern Panalytical's materials characterization portfolio. The agreement will give Malvern Panalytical exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

American Brain Tumor Association awards $100,000 clinical research grant

The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kimberly Ann Bailey Dexter is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Kimberly Ann Bailey Dexter, NURSE PRACTITIONER
6801 Lucy Corr Ct,
Chesterfield, VA 23832-6657

Ph: () -
Dr Kimberly Ann Bailey Dexter, NURSE PRACTITIONER
6801 Lucy Corr Ct,
Chesterfield, VA 23832-6657

Ph: (804) 751-7215

News Archive

Sports playbook can help generate more accurate prognoses for cancer patients

In this season of global soccer competitions and hotly contested political primaries, bookies and pundits are scouring every evolving scrap of information and sifting through mountains of data in an effort to predict the outcome of the next game or election.

Malvern and Paraytec enter into development and technology licensing agreement

Malvern Panalytical (Malvern Panalytical, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix® technology being added to Malvern Panalytical's materials characterization portfolio. The agreement will give Malvern Panalytical exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.

China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine

Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.

American Brain Tumor Association awards $100,000 clinical research grant

The Section on Tumors of the American Association of Neurological Surgeons and Congress of Neurological Surgeons has announced a $100,000 two-year ($50,000/year) clinical research grant funded by the American Brain Tumor Association (ABTA). The application is open exclusively to neurosurgeons who are members of the AANS/CNS Section on Tumors.

Read more News

› Verified 9 days ago


Nurse Practitioner Nurses in Chesterfield, VA

Golda Trompeta, PMHNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 7931 Mill River Ln, Chesterfield, VA 23832
Phone: 804-519-2823    
Hannah Braxton, NP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 5625 Burnage Ct, Chesterfield, VA 23832
Phone: 804-878-3518    
Mrs. Laura Joyce Jensen, N.P.
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 6800 Lucy Corr Ct, Chesterfield, VA 23832
Phone: 804-318-8584    Fax: 804-748-5054
Elethia Moore, NP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 6801 Lucy Corr Ct, Chesterfield, VA 23832
Phone: 804-768-7318    
Patricia Hardy Lavinus, FNP-BC
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 11102 Rabbit Ridge Rd, Chesterfield, VA 23838
Phone: 804-387-5820    
Germaine Kelley-pope, MSN APRN PMHNP-BC
Nurse Practitioner
Medicare: May Accept Medicare Assignments
Practice Location: 9844 Lori Rd Ste 101, Chesterfield, VA 23832
Phone: 804-615-5118    Fax: 804-207-8831
Portia Thelwell, NP-C
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 6800 Lucy Corr Boulevard, Chesterfield, VA 23832
Phone: 804-318-8584    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.